Yunmeng Liu | Biomedical Sciences | Best Researcher Award

Published on by Natural Scientist Awards

Assist. Prof. Dr. Yunmeng Liu | Biomedical Sciences | Best Researcher Award

Assist. Prof. Dr. Yunmeng Liu | University of Arkansas for Medical Sciences (UAMS) | United States

Assist. Prof. Dr. Yunmeng Liu is an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences. She earned her doctorate in Integrated Biomedical Science from New York Medical College and a bachelor’s degree in Molecular Biology from the Beijing Institute of Technology. Her research focuses on the interplay of immunity, diabetes, and hypertension, supported by competitive funding from organizations such as the NIH and the American Heart Association. With a strong record of publications, teaching, and scientific service, she contributes significantly to advancing biomedical and pharmacological research.

Publication Profile

Orcid

Academic Background

Assist. Prof. Dr. Yunmeng Liu is an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences. She completed her doctoral studies in Integrated Biomedical Science at New York Medical College after earning a bachelor’s degree in Molecular Biology from the Beijing Institute of Technology. Her academic journey laid the foundation for her research in the fields of pharmacology, toxicology, and biomedical sciences. With a focus on the connections between immunity, diabetes, and hypertension, she has established a strong reputation through research, teaching, mentoring, and contributions to scientific advancement.

Professional Experience

Assist. Prof. Dr. Yunmeng Liu serves as an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences. She has built her career through progressive roles in academic research, advancing from postdoctoral training to staff scientist and then to faculty positions. Her professional journey reflects a strong commitment to biomedical research, particularly in the areas of immunity, diabetes, and hypertension. Alongside her laboratory work, she contributes to graduate teaching, mentorship, and scientific peer review, showcasing a balanced career that integrates research excellence with academic service and community engagement.

Awards and Honors

Assist. Prof. Dr. Yunmeng Liu has been recognized for her dedication and contributions to biomedical research through multiple awards and honors during her academic journey. She has received recognition for her outstanding presentations at international scientific conferences and was honored with travel awards that supported her active participation in global research forums. These achievements reflect her commitment to advancing knowledge in pharmacology, toxicology, and biomedical sciences. Her growing reputation as a promising researcher is further highlighted by the acknowledgment of her innovative work, positioning her as a respected figure in the scientific community with a record of excellence.

Research Focus

Assist. Prof. Dr. Yunmeng Liu concentrates her research on the complex interactions between the immune system, metabolic disorders, and cardiovascular diseases. Her studies explore how immune mechanisms contribute to the development of diabetes and hypertension, with a particular focus on the role of T cells in metabolic and vascular regulation. By investigating these connections, her work provides critical insights into the pathways that link chronic inflammation with major health challenges. Through innovative research approaches, she aims to identify new therapeutic strategies that can improve the prevention and treatment of metabolic and cardiovascular complications worldwide.

Publication Top Notes

Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications

Year: 2025

Immune Disorders Connecting Type 2 Diabetes and Cardiovascular Complications

Year: 2024

P2X7-Mediated Antigen-Independent Activation of CD8T Cells Promotes Salt-Sensitive Hypertension

Year: 2024 | Cited by: 5

The Link Between Immunity and Hypertension in the Kidney and Heart

Year: 2023 | Cited by: 12

IFNγ Contributes to the Immune Mechanisms of Hypertension

Year: 2022 | Cited by: 18

Conclusion

Assist. Prof. Dr. Yunmeng Liu is an accomplished researcher and educator whose work bridges pharmacology, toxicology, immunology, and cardiovascular sciences. She has built a strong academic profile through impactful publications in respected journals, competitive research funding, and meaningful contributions to advancing biomedical science. Her studies focus on the links between immunity, diabetes, and hypertension, offering innovative insights with clinical relevance. With her leadership, teaching, and commitment to mentorship, she stands out as a highly deserving candidate for the Best Researcher Award.

 

Editha Renesteen | Microbiome | Best Researcher Award

Published on by Natural Scientist Awards

Ms. Editha Renesteen | Microbiome | Best Researcher Award

Ms. Editha Renesteen at McGill University, Canada

Editha Renesteen is a PhD candidate in Biological & Biomedical Engineering at McGill University, supported by the prestigious LPDP scholarship. With an MSc in Medical Biotechnology from Wageningen University, she focuses on microbiome research and Alzheimer’s disease 🧠. Editha has authored impactful publications, led COVID-19 testing efforts, and guided students in publishing their own research. As a lecturer and project leader, she achieved ISO and national accreditation milestones 🏅. Her achievements in global hackathons, science communication, and academic leadership make her a passionate and inspiring emerging researcher.📚🌍🎥

Publication Profile📚

Orcid

Scopus

Google Scholar

Academic Background🎓

Editha Renesteen is a dedicated PhD candidate in Biological & Biomedical Engineering at McGill University, supported by the prestigious LPDP scholarship. She holds an MSc in Medical Biotechnology from Wageningen University , where she gained expertise in advanced biotechnological research 🧬. Her academic journey began with a Bachelor’s degree in Pharmacy and a Pharmacist certification from Universitas Indonesia. Throughout her education, Editha has demonstrated excellence in research, presenting at international conferences 🌍 and publishing scientific papers 📚. Her strong educational foundation continues to fuel her impactful work in microbiome science and Alzheimer’s disease research 🧠.

Professional Experience💼

Editha Renesteen has built a diverse and impactful professional career in academia and research 🌟. Currently a PhD candidate at McGill University, she leads research on microbiome and Alzheimer’s disease 🧠. She previously served as a lecturer at the Republic of Indonesia Defense University and Swiss German University, mentoring students to publish scientific papers 📄. As a research assistant at IMERI-FKUI, she played a key role in nationwide COVID-19 RT-PCR testing 🧪. Editha has also led projects achieving ISO 21001:2018 certification 🏅 and national academic accreditation, showcasing her leadership in both scientific and educational excellence 🌍.

Awards and Honors🏅

Editha Renesteen has received numerous prestigious awards in recognition of her academic excellence and leadership. She is a two-time recipient of the Indonesia Endowment Fund for Education (LPDP) scholarship, supporting both her MSc and PhD studies. In 2024, she won second place in HackMedTech Canada 🧠, an innovation hackathon tackling real-world medical challenges. She was also selected as one of only 25 global participants in the 2023 DAAD UNILEAD program in Germany, focusing on academic leadership and project management. These honors reflect her commitment to impactful research, innovation, and global collaboration🎓🌟🌍.

Research Focus🔬

Editha Renesteen’s research is centered on the intersection of microbiome science and neurodegenerative diseases 🧠, with a special focus on Alzheimer’s disease. As a PhD candidate at McGill University, she explores how gut–brain axis modulation can lead to innovative biotherapeutics 🌿. Her work integrates molecular biology, microbiome engineering 🧬, and biomedical innovation to uncover novel treatment pathways. With several publications in high-impact journals 📚, Editha also contributes to studies on infectious diseases, including HIV, tuberculosis, and COVID-19 🦠. Her multidisciplinary approach and commitment to translational science drive meaningful progress in global health research 🌍.

Publication Top Notes📄

Microbiome Engineering for Biotherapeutic in Alzheimer’s Disease Through the Gut–Brain Axis
Year: 2025 | Cited by: 2 📑

Select Probiotics Exhibit Antioxidative and Anti-Inflammatory Properties for Gut Modulation: In Vitro Analysis
Year: 2024 | Cited by: 4 📑

Baculovirus Expressing Tumor Growth Factor-β1 Nanoshuttle Augments Therapeutic Effects for Vascular Wound Healing
Year: 2024 | Cited by: 3 📑

The Regenerative Potential of Pax3/Pax7 on Skeletal Muscle Injury
Year: 2022 | Cited by: 5 📑

Recent Advances in the Diagnosis of Intestinal Tuberculosis
Year: 2022 | Cited by: 8 📑

Conclusion🌟

In conclusion, Editha Renesteen stands out as an exceptional candidate for the Best Researcher Award, particularly in the emerging researcher category. With a robust academic background including a PhD in progress at McGill University and an MSc from Wageningen University, she has demonstrated excellence in interdisciplinary research on the microbiome and Alzheimer’s disease. Her impactful publications in high-ranking journals, leadership in academic accreditation and ISO certification, and hands-on role in national COVID-19 efforts reflect her dedication to advancing science and public health. Recognized internationally through awards like HackMedTech and DAAD UNILEAD, Editha exemplifies innovation, leadership, and global research impact.

 

 

Sergio Santaeufemia Sánchez | Biotechnology | Best Researcher Award

Published on by Natural Scientist Awards

Dr. Sergio Santaeufemia Sánchez | Biotechnology | Best Researcher Award

Postdoctoral Researcher at Technical University of Munich Human Spaceflight Technology, Germany

Sergio Santaeufemia Sánchez is a postdoctoral researcher at the Technical University of Munich (TUM) in the Professorship of Human Spaceflight Technology 🚀. With a PhD in Biotechnology from the University of A Coruña 🧪, his work bridges life sciences and aerospace engineering. Sergio investigates microalgae-based life support systems for future space habitats 🌿🌕, contributing to oxygen production, water purification, and edible biomass cultivation. His interdisciplinary expertise spans microbiology, biotechnology, and space systems engineering 🌌. He also supervises students and teaches courses on human spaceflight technology and life support systems at TUM 🎓.

Publication Profile

Orcid

Academic Background

Sergio earned his PhD in Biotechnology from the University of A Coruña (UDC), Spain , specializing in microalgae-based bioremediation 🌊. His doctoral research focused on pollutant removal using extremophilic microalgae under challenging environmental conditions. During his academic journey, he gained advanced knowledge in molecular biology, photosynthesis, and microbial stress responses 🧫. This foundation paved the way for his interdisciplinary shift to aerospace research at the Technical University of Munich . He has also been trained in space systems, photobioreactor design, and life support engineering to support long-term human missions in space 🛰️.

Professional Experience

Sergio has held research positions in Spain,Poland , and Germany, contributing to biotechnology and aerospace engineering. He began at the Centre for New Technologies (CeNT), researching microalgae under extreme conditions 🔬. At the Technical University of Munich, he applies his biotechnology background to develop photobioreactors for astronaut life support 🚀. His international collaborations include partners from Italy and the USA. Sergio has managed and contributed to multiple European-funded projects (HORIZON-EIC, BIODIVERSA+, NCN) 💡. He also supervises students, leads experiments, and organizes outreach events like Space Day Ottobrunn 🌍.

Awards and Honors

Sergio has been part of numerous prestigious European research projects, including HORIZON-EIC and BIODIVERSA+ . He received NCN MINIATURA and OPUS research grants in Poland for his pioneering work on extremophilic microalgae 🧪. His studies have appeared in high-impact journals and gained international recognition 🌐. Sergio co-organized key space events like the Space Station Design Workshop (SSDW) and Space Day Ottobrunn 🛰️. His work has led to over 330 citations, an h-index of 8, and 10 peer-reviewed publications 📚. His contributions highlight his excellence in combining space research and biotechnology 🚀🌱.

Research Focus

Sergio focuses on extremophilic microalgae to support life in space through oxygen production, water purification, and food generation 🌿💧🍽️. He explores their stress adaptation mechanisms to enhance bioremediation techniques on Earth and in extraterrestrial environments 🌍🌕. His research integrates transcriptomics, photobioreactor design, and microbial ecology, targeting space applications such as lunar or Mars habitats 🪐. He is currently involved in designing space-compatible life support systems and experiments for parabolic flights and lunar simulations 🚀. Sergio’s interdisciplinary approach bridges biotechnology, life sciences, and aerospace engineering to push the boundaries of human spaceflight 🌌.

Publication Top Notes

📄 Bioremediation of oxytetracycline in seawater by living and dead biomass of the microalga Phaeodactylum tricornutum

📅 Year: 2016 | 📚 Journal of Hazardous Materials | 🔁 Cited by: 109 | 🧪🌊

📄 Biosorption of ibuprofen from aqueous solution using living and dead biomass of the microalga Phaeodactylum tricornutum

📅 Year: 2018 | 📚 Journal of Applied Phycology | 🔁 Cited by: 62 | 💊🌱

📄 Bioaugmentation as a strategy to enhance nutrient removal: Symbiosis between Chlorella protothecoidesand Brevundimonas diminuta

📅 Year: 2018 | 📚 Bioresource Technology Reports | 🔁 Cited by: 36 | 🧫💧

📄 Light intensity affects the mixotrophic carbon exploitation in Chlorella protothecoides: consequences on microalgae-bacteria based wastewater treatment

📅Year: 2018 | 📚Water Science and Technology | 🔁Cited by: 20 | 🌞💡

Conclusion

Dr. Sergio Santaeufemia Sánchez is an outstanding candidate for the Best Researcher Award, distinguished by his innovative and interdisciplinary work at the intersection of biotechnology, environmental science, and space technology. With a strong portfolio of high-impact international research projects (e.g., HORIZON-EIC, BIODIVERSA+), he has advanced novel applications of extremophile microalgae for bioremediation and life support systems in space missions. Despite being at an early stage in his career, he has achieved a notable h-index of 8 with 10 SCI-indexed publications, often as first or leading author, reflecting both academic impact and leadership. His collaborations span leading global institutions across diverse fields such as biology, physics, and aerospace engineering, demonstrating his capacity for cross-disciplinary integration. Dr. Santaeufemia’s work directly addresses global environmental challenges and contributes to the future of human spaceflight, while his supervision of students and science outreach efforts highlight his commitment to education and public engagement.

 

Purna Chetri | Biochemistry | Best Researcher Award

Published on by Natural Scientist Awards

Dr. Purna Chetri | Biochemistry | Best Researcher Award

Project Scientist at Assam Agricultural University, India

Purna Bahadur Chetri is a dedicated biochemist with a Ph.D. from North Eastern Hill University, India 🧪. His research spans molecular biology, protein biochemistry, and parasitology, with numerous publications in high-impact journals 📚. He has gained experience from prestigious institutions such as IIT Bombay and international exposure through the Newton-Bhabha Fellowship 🌍. Currently, he is a Project Scientist at DBT-NECAB, Assam Agricultural University 🌾. With a track record of academic excellence and research innovation, Chetri remains committed to contributing to scientific advancement and public health through biochemical and biotechnological research 💡.

Publication Profile

Google Scholar

Orcid

Scopus

Academic Background

Purna B. Chetri earned his Ph.D. in Biochemistry (2016–2021) from North Eastern Hill University, Shillong, India, where he also completed his M.Sc. (2013–2015) with First Division and topped his class 🥇. He began his academic journey with a B.Sc. in Biochemistry (2010–2013) from St. Edmund’s College under NEHU, also graduating with First Division 🎓. His education was supported by prestigious fellowships including DST-INSPIRE, and enriched by international exposure through the Newton-Bhabha PhD Placement Program in the UK 🇬🇧. Throughout his academic journey, Chetri consistently demonstrated excellence and a strong commitment to biochemical sciences 🔍.

Professional Experience

Dr. Chetri is currently working as a Project Scientist at DBT-NECAB, Assam Agricultural University (since August 2023) 🔬. He previously served as Research Associate III at ICMR-RMRC, Dibrugarh (April–July 2023), and as a Researcher at IIT Bombay (2022–2023) 🧬. With expertise in molecular biology, protein purification, and biophysical assays, he has contributed significantly to multiple national and international research projects 🧑‍🔬. His interdisciplinary experience spans biochemistry, parasitology, and bioengineering, equipping him with a versatile research profile and practical skills in both laboratory and computational biology 🧫🧑‍💻.

Awards and Honors

Dr. Chetri has received numerous accolades, including the DST-INSPIRE JRF & SRF fellowships (2016–2021) 🧠, and the Newton-Bhabha PhD fellowship for research in the UK 🌍. He was the recipient of the Shankar Dayal Sharma Presidential Gold Medal, Rector Gold Medal, and U Kiang Nangbah Award for topping his M.Sc. program 🥇. He earned 1st prize for oral presentation at an international conference at Assam Agricultural University 🗣️. Additionally, he received a travel grant for ICOPA 2018 in South Korea ✈️, and has presented his work at various national and international conferences 📢.

Research Focus

Dr. Chetri’s research focuses on protein biochemistry, structural biology, and parasitology 🧪. He has studied key enzymes from Fasciola gigantica, contributing to understanding their biochemical mechanisms and potential as drug targets 🐛. His work also includes CRISPR/Cas gene editing, protein folding/unfolding, and acid tolerance mechanisms in microbes 🧬. He has authored multiple peer-reviewed articles and book chapters on experimental and computational techniques related to protein characterization 📘. With a growing interest in agricultural waste management and zoonotic diseases, Chetri’s multidisciplinary approach bridges fundamental science with translational research and public health impact 🌱💊.

Publication Top Notes

📚 Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation
📅 Year: 2018 | 📊 Cited by: 41 | 🧪 Journal of Biomolecular Structure and Dynamics

📚 Draft Genome of the Liver Fluke Fasciola gigantica
📅 Year: 2020 | 📊 Cited by: 35 | 🔬 ACS Omega

📚 Experimental methods to study intrinsically disordered proteins
📅 Year: 2022 | 📊 Cited by: 12 | 🧬 Advances in Protein Molecular and Structural Biology Methods

📚 Identification and characterization of cytosolic malate dehydrogenase from the liver fluke Fasciola gigantica
📅 Year: 2020 | 📊 Cited by: 12 | 🧫 Scientific Reports

Conclusion

Dr. Purna Bahadur Chetri is an accomplished early-to-mid-career biochemist whose strong academic foundation (Ph.D. in Biochemistry), top-ranking educational achievements, and prestigious fellowships (DST-INSPIRE, Newton-Bhabha) mark him as an exceptional talent. With over 12 publications in reputed journals like ACS Infectious Diseases, Scientific Reports, and Frontiers in Microbiology, he showcases a commendable blend of innovative research and technical depth. His international collaborations, technical proficiency in molecular biology and structural bioinformatics, and hands-on experience with modern tools like CRISPR and FPLC position him at the forefront of biomedical science. Recognized with multiple awards and currently serving as a Project Scientist, Dr. Chetri exemplifies excellence, making him a highly deserving candidate for the Best Researcher Award.